Singapore National Eye Centre
Mo Dirani is the Chairman and Founding Managing Director of Plano, a company focused on managing smart device use and myopia in children. Mo is also an Adjunct Associate Professor at Duke-NUS Medical School and a SERI Adjunct Principal Investigator at the Singapore Eye Research Institute. Additionally, they have served as an Honorary Fellow at the Centre for Eye Research Australia (CERA) and as an Academic Fellow at the Baker IDI Heart and Diabetes Institute. In the past, Dirani has held positions as a Principal Investigator at the Centre for Eye Research Australia and as a Fellow at the Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital. Mo also has experience as a Postdoctoral Research Fellow at the Singapore Eye Research Institute.
Mo Dirani obtained a PhD in Medicine from the University of Melbourne between 2004 and 2006. In 2013, they completed a Board Director course at the Australian Institute of Company Directors. Mo also earned a Master of Business Administration (MBA) with a focus on Entrepreneurship/Entrepreneurial Studies from the Australian Institute of Business between 2015 and 2016. Additionally, Mo Dirani received certifications from Huawei in the AppsUP 2021 - Huawei HMS App Innovation Contest, including the Best Social Impact Award and the Most Popular App Award.
This person is not in any offices
Singapore National Eye Centre
1 followers
Singapore National Eye Centre (SNEC) is the designated national centre within the public sector healthcare network, and spearheads and coordinates the provision of specialised ophthalmological services with emphasis on quality education and research. Information about SNEC branches and affiliated clinics are available on our website. Singapore Eye Research Institute (SERI) is the national research institute for ophthalmic and vision research in Singapore. SERI undertakes vision research in collaboration with local clinical ophthalmic centres and biomedical research institutions, as well as major eye centres and research institutes throughout the world. ------------------------------------------------ To help ensure that online interaction on our social media pages remains meaningful and valuable to everyone, please observe these guidelines: 1. No personal criticism and/or defamatory attacks on SNEC/SERI/SingHealth staff or other LinkedIn users 2. Derogatory comments on issues such as race, religion, ethnicity, gender and disability will be removed 3. Abusive remarks will not be tolerated 4. Posting of personal information is not allowed 5. Be respectful of other members of the community. Please do not post any inappropriate content. 6. Please do not post spam or advertisements. Check out our guidelines for participation here: https://www.snec.com.sg/about-us/corporate-profile/social-media-community-guidelines